Humanigen is taking action on the novel coronavirus outbreak. Refer to this page for the latest educational resources and information on lenzilumab as a therapeutic for cytokine storm resulting from COVID-19 infection.
Learn how Lenzilumab may reduce serious or fatal outcomes in COVID-19 patients
Captions available (enable using video controls)
Available languages: English, Spanish (Español), Mandarin (國語), Cantonese (廣東話), Korean (한국어, 韓國語), French (Français), German (Deutsch), Italian (Italiano), Portuguese (Português)